335106-46-2

Upstream product

• 335106-42-8 3-O-TBDMS-17S,20S-dihydrofusidin-3,11,16,21-tetrol 
• 335106-40-6 3-O-TBDMS-17S,20S-dihydrofusidic acid lactone 
• 4701-60-4 17S,20R-dihydrofusidic acid lactone 
• 335106-26-8 17S,20S-dihydrofusidic acid lactone 
• 4701-54-6 (1S,2R,4aS,4bS,5R,6aR,9aS,10aS,10bS,12aS)-2,5-dihydroxy-1,4a,10a,10b-tetramethyl-7-(4-methylpent-3-en-1-yl)-1,2,3,4,4a,4b,5,6,6a,9a,10,10a,10b,11,12,12a-hexadecahydro-8H-naphtho[2′,1′:4,5]indeno[2,1-b]-furan-8-one 
• 3482-49-3 fusidine 
• 108-24-7 acetic anhydride 
• 335106-44-0 3-O-TBDMS-21-O-diphenylmethylsilyl-17S,20S-dihydrofusidin-3,11,16,21-tetrol 

Relevant academic research and scientific papers

Synthesis and conformational analysis of fusidic acid side chain derivatives in relation to antibacterial activity

Novel fusidic acid type antibiotics having flexible side chains are described. Saturation of the double bond between C-17 and C-20 of fusidic acid produces four stereoisomers differing in the configuration at C-17 and C-20. The structure-activity relation